385 related articles for article (PubMed ID: 27913470)
21. Gut microbiota and hematopoietic stem cell transplantation: where do we stand?
Zama D; Biagi E; Masetti R; Gasperini P; Prete A; Candela M; Brigidi P; Pession A
Bone Marrow Transplant; 2017 Jan; 52(1):7-14. PubMed ID: 27348539
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathological comparison between acute gastrointestinal-graft-versus-host disease and infectious colitis in patients after hematopoietic stem cell transplantation.
Ohwada S; Iida T; Hirayama D; Sudo G; Kubo T; Nojima M; Yamashita K; Yamano H; Nakase H
PLoS One; 2018; 13(7):e0200627. PubMed ID: 30059537
[TBL] [Abstract][Full Text] [Related]
23. The gastrointestinal tract: properties and role in allogeneic hematopoietic stem cell transplantation.
Pessach I; Tsirigotis P; Nagler A
Expert Rev Hematol; 2017 Apr; 10(4):315-326. PubMed ID: 28136133
[TBL] [Abstract][Full Text] [Related]
24. The gut microbiota and graft-versus-host disease.
Fredricks DN
J Clin Invest; 2019 May; 129(5):1808-1817. PubMed ID: 31042160
[TBL] [Abstract][Full Text] [Related]
25. Relationship between clostridium difficile infection and gastrointestinal graft versus host disease in recipients of allogeneic stem cell transplantation.
Bhutani D; Jaiyeoba C; Kim S; Naylor P; Uberti JP; Ratanatharathorn V; Ayash L; Deol A; Alavi A; Revankar S; Chandrasekar P
Bone Marrow Transplant; 2019 Jan; 54(1):164-167. PubMed ID: 30038352
[No Abstract] [Full Text] [Related]
26. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
Stecher B
Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
[TBL] [Abstract][Full Text] [Related]
27. Interplay Between the Intestinal Microbiota and Acute Graft-Versus-Host Disease: Experimental Evidence and Clinical Significance.
Hong T; Wang R; Wang X; Yang S; Wang W; Gao Q; Zhang X
Front Immunol; 2021; 12():644982. PubMed ID: 33815399
[TBL] [Abstract][Full Text] [Related]
28. Ileostomy for steroid-resistant acute graft-versus-host disease of the gastrointestinal tract.
Turki AT; Bayraktar E; Basu O; Benkö T; Yi JH; Kehrmann J; Tzalavras A; Liebregts T; Beelen DW; Steckel NK
Ann Hematol; 2019 Oct; 98(10):2407-2419. PubMed ID: 31338570
[TBL] [Abstract][Full Text] [Related]
29. A Genetic Modifier of the Gut Microbiome Influences the Risk of Graft-versus-Host Disease and Bacteremia After Hematopoietic Stem Cell Transplantation.
Rayes A; Morrow AL; Payton LR; Lake KE; Lane A; Davies SM
Biol Blood Marrow Transplant; 2016 Mar; 22(3):418-22. PubMed ID: 26643031
[TBL] [Abstract][Full Text] [Related]
30. Biology-driven developments in the therapy of acute graft-versus-host disease.
Zeiser R
Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):236-241. PubMed ID: 30504316
[TBL] [Abstract][Full Text] [Related]
31. The Intestinal Epithelium: Central Coordinator of Mucosal Immunity.
Allaire JM; Crowley SM; Law HT; Chang SY; Ko HJ; Vallance BA
Trends Immunol; 2018 Sep; 39(9):677-696. PubMed ID: 29716793
[TBL] [Abstract][Full Text] [Related]
32. The Gut Microbiota and Hematopoietic Stem Cell Transplantation: Challenges and Potentials.
Noor F; Kaysen A; Wilmes P; Schneider JG
J Innate Immun; 2019; 11(5):405-415. PubMed ID: 30286447
[TBL] [Abstract][Full Text] [Related]
33. The interaction of intestinal microbiota and innate lymphoid cells in health and disease throughout life.
Ganal-Vonarburg SC; Duerr CU
Immunology; 2020 Jan; 159(1):39-51. PubMed ID: 31777064
[TBL] [Abstract][Full Text] [Related]
34. Intestinal Microbiota at Engraftment Influence Acute Graft-Versus-Host Disease
Han L; Jin H; Zhou L; Zhang X; Fan Z; Dai M; Lin Q; Huang F; Xuan L; Zhang H; Liu Q
Front Immunol; 2018; 9():669. PubMed ID: 29740427
[TBL] [Abstract][Full Text] [Related]
35. Interaction Between the Microbiota, Epithelia, and Immune Cells in the Intestine.
Kayama H; Okumura R; Takeda K
Annu Rev Immunol; 2020 Apr; 38():23-48. PubMed ID: 32340570
[TBL] [Abstract][Full Text] [Related]
36. Challenges and opportunities targeting mechanisms of epithelial injury and recovery in acute intestinal graft-versus-host disease.
Jansen SA; Nieuwenhuis EES; Hanash AM; Lindemans CA
Mucosal Immunol; 2022 Apr; 15(4):605-619. PubMed ID: 35654837
[TBL] [Abstract][Full Text] [Related]
37. The association between the incidence of intestinal graft-vs-host disease and antibiotic use after allogeneic hematopoietic stem cell transplantation.
Hidaka D; Hayase E; Shiratori S; Hasegawa Y; Ishio T; Tateno T; Okada K; Goto H; Sugita J; Onozawa M; Nakagawa M; Kahata K; Endo T; Hashimoto D; Teshima T
Clin Transplant; 2018 Sep; 32(9):e13361. PubMed ID: 30054935
[TBL] [Abstract][Full Text] [Related]
38. [Intestinal microbiota and allogeneic stem cell transplantation].
Dougé A; Bay JO; Ravinet A; Scanzi J
Bull Cancer; 2020 Jan; 107(1):72-83. PubMed ID: 31582175
[TBL] [Abstract][Full Text] [Related]
39. Crypt loss is a marker of clinical severity of acute gastrointestinal graft-versus-host disease.
Melson J; Jakate S; Fung H; Arai S; Keshavarzian A
Am J Hematol; 2007 Oct; 82(10):881-6. PubMed ID: 17570511
[TBL] [Abstract][Full Text] [Related]
40. Pathology of graft-versus-host disease in the gastrointestinal tract.
Washington K; Jagasia M
Hum Pathol; 2009 Jul; 40(7):909-17. PubMed ID: 19524102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
